Symbol | Exchange | Currency |
|---|
By Davit Kirakosyan Barclays initiated coverage on Target (NYSE:TGT) with an Equalweight rating and a price target of $163.00. BTIG initiated coverage on Foot Locker (NYSE:FL)...
Orchestra BioMed Holdings, Inc. is a biomedical company. It is engaged in developing technologies for patients through risk-reward sharing partnerships with medical device companies. Its flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) and Virtue Sirolimus AngioInfusion Balloon (SAB). BackBeat CNT is a bioelectronic treatment for hypertension that is designed to drive an immediate reduction in blood pressure while simultaneously modulating autonomic nervous system responses to maintain the reduction. Virtue SAB is a patented drug/device combination product candidate in development for the treatment of certain forms of artery disease that is designed to deliver an investigational, extended-release formulation of sirolimus, SirolimusEFR, to the vessel wall during balloon angioplasty without any coating on the balloon surface or the need to leave a stent or other permanent implant in the artery.
| Average | 20.33 (+29.26% Upside) |
| High | 21.00 |
| Low | 20.00 |
| Price | 15.73 |
| No. of Analysts | 3 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.62 | 0.91 | 0.62 | -0.21 | -24.95% | 4.26M | NASDAQ | |||
| 0.40 | 0.45 | 0.33 | +0.07 | +21.21% | 1.13M | OTC Markets | |||
| 3.89 | 3.90 | 3.645 | +0.240 | +6.58% | 110.64K | NASDAQ | |||
| 376.30 | 397.98 | 370.00 | +82.34 | +28.01% | 9.09M | NASDAQ | |||
| 151.74 | 155.00 | 148.77 | -2.18 | -1.42% | 1.16M | NYSE | |||
| 142.39 | 147.58 | 140.16 | +7.30 | +5.40% | 8.01M | NASDAQ | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 133.45 | 135.45 | 132.17 | +2.66 | +2.03% | 2.63M | NASDAQ | |||
| 34.25 | 34.64 | 32.71 | -0.03 | -0.09% | 11.42M | NYSE | |||
| 63.46 | 63.99 | 61.27 | +1.96 | +3.19% | 10.60M | NYSE | |||
| 8.52 | 8.68 | 8.48 | -0.160 | -1.84% | 256.49K | OTC Markets | |||
| 5.80 | 5.80 | 5.80 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 2.52 | 2.52 | 2.52 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 35.80 | 37.60 | 35.30 | -1.4 | -3.79% | 39.04K | OTC Markets |